CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $4.80 million. The enterprise value is $3.19 million.
Important Dates
The last earnings date was Friday, May 29, 2026, before market open.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 14.42 million shares outstanding. The number of shares has increased by 11.54% in one year.
| Current Share Class | 14.42M |
| Shares Outstanding | 14.42M |
| Shares Change (YoY) | +11.54% |
| Shares Change (QoQ) | +7.52% |
| Owned by Insiders (%) | 28.46% |
| Owned by Institutions (%) | 12.03% |
| Float | 10.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.34 |
| Forward PS | 3.18 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.54.
| Current Ratio | 2.27 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -151.99% and return on invested capital (ROIC) is -71.08%.
| Return on Equity (ROE) | -151.99% |
| Return on Assets (ROA) | -61.34% |
| Return on Invested Capital (ROIC) | -71.08% |
| Return on Capital Employed (ROCE) | -192.11% |
| Weighted Average Cost of Capital (WACC) | 5.00% |
| Revenue Per Employee | $9,974 |
| Profits Per Employee | -$336,769 |
| Employee Count | 39 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.13% in the last 52 weeks. The beta is 0.64, so CLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -77.13% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 35.31 |
| Average Volume (20 Days) | 86,389 |
Short Selling Information
The latest short interest is 42,484, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 42,484 |
| Short Previous Month | 84,316 |
| Short % of Shares Out | 0.40% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.73 |
Income Statement
In the last 12 months, CLGN had revenue of $389,000 and -$13.13 million in losses. Loss per share was -$1.03.
| Revenue | 389,000 |
| Gross Profit | -574,000 |
| Operating Income | -12.95M |
| Pretax Income | -13.13M |
| Net Income | -13.13M |
| EBITDA | -12.07M |
| EBIT | -12.95M |
| Loss Per Share | -$1.03 |
Full Income StatementBalance Sheet
The company has $4.26 million in cash and $2.65 million in debt, giving a net cash position of $1.61 million or $0.11 per share.
| Cash & Cash Equivalents | 4.26M |
| Total Debt | 2.65M |
| Net Cash | 1.61M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 4.89M |
| Book Value Per Share | 0.34 |
| Working Capital | 3.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.30 million and capital expenditures -$25,000, giving a free cash flow of -$11.33 million.
| Operating Cash Flow | -11.30M |
| Capital Expenditures | -25,000 |
| Depreciation & Amortization | 878,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.33M |
| FCF Per Share | -$0.79 |
Full Cash Flow StatementMargins
| Gross Margin | -147.56% |
| Operating Margin | -3,329.05% |
| Pretax Margin | -3,376.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |